Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dylan Skola
SF2523: Dual PI3K/BRD4 Inhibitor Blocks Tumor Immunosuppression and Promotes Adaptive Immune Responses in Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo
Cellular Physiology and Biochemistry
Physiology
Dual Inhibition of BRD4 and PI3K-AKT by SF2523 Suppresses Human Renal Cell Carcinoma Cell Growth
Oncotarget
Oncology
KRASG12D Promotes Immunosuppression in Colorectal Cancer
Cancer Discovery
Oncology
Elimination of Tumor by CD47/PD-L1 Dual-Targeting Fusion Protein That Engages Innate and Adaptive Immune Responses
mAbs
Allergy
Immunology
PI3K- Inhibitor Produces Long-Lasting Responses
Cancer Discovery
Oncology
Prostate Cancer Stem Cells Are Targets of Both Innate and Adaptive Immunity and Elicit Tumor-Specific Immune Responses
OncoImmunology
Oncology
Allergy
Immunology
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Clinical Cancer Research
Cancer Research
Oncology
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Nab-Paclitaxel Antitumor Response in Experimental Gastric Cancer
International Journal of Oncology
Cancer Research
Oncology
Pd32-01 Pre-Clinical Rationale for Combination Pi3k and Brd4 Inhibition in Advanced Prostate Cancer
Journal of Urology
Urology